Richard Aldrich, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 30,000 shares at $19.03 ($580K) on 2018-01-17, disclosed to the SEC on 2018-01-19.
Open-market sale of $580k CNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.95 | 5,000 | $95K | 16.3% |
| 2 | $19.03 | 5,000 | $95K | 16.4% |
| 3 | $19.36 | 5,000 | $97K | 16.7% |
| 4 | $19.43 | 5,000 | $97K | 16.7% |
| 5 | $19.65 | 5,000 | $98K | 16.9% |
| 6 | $19.66 | 5,000 |
| $98K |
| 16.9% |
| Total | $19.35 avg | 30,000 | $580K | 100% |
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |